Microbiological screening of malignant otitis externa patients at Sohag University Hospitals
Official title: Microbiological Screening Of Malignant Otitis Externa Patients Presenting at Sohag University Hospitals
Run by Sohag University · NCT07790679 · Data updated 2026-11-12
This study tests which bacteria and fungi cause malignant otitis externa in patients seen at Sohag University Hospitals and how they respond to antibiotics.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag, Sohag Governorate) |
| Status | Recruiting |
| Started | September 2026 |
| Main results expected | September 2027 |
| Study ends | October 2027 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT07790679 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are patients with a clinical diagnosis of malignant otitis externa seen at Sohag University Hospitals, especially those with risk factors like diabetes or immunocompromise.
✕Probably not a fit
Patients without MOE or those who do not have pathogens detected may not gain direct benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective cross-sectional study collects ear swabs from patients diagnosed with malignant otitis externa at Sohag University Hospitals. The samples undergo culture, organism identification, and antibiotic susceptibility testing to map the common pathogens and their resistance patterns. The goal is to inform more effective empirical treatment choices for MOE in this geographic area. Data on patient demographics and clinical features will also be recorded. No interventions beyond standard culture testing are performed.
Why it matters
Potential benefit: Results could help clinicians choose more effective antibiotics for MOE based on local pathogen profiles.
How similar studies have gone: Prior MOE studies have shown that local microbiological profiles can vary, but similar pathogen-targeted approaches have informed treatment in other settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients clinically diagnosed with MOE based on severe otalgia, external auditory canal inflammation ± granulation tissue. * Patients with risk factors such as DM, Immunocompromised patients. Exclusion Criteria: * Post-operative ear cases (recent ear surgery). * Patients with external auditory canal tumors. * Patient refusal
Where it's running
-
Sohag University Hospitals
Sohag, Sohag Governorate, Egypt Recruiting
Study contacts
- Study coordinator: Omar Ashraf Mohamed
- Email: omarashraf833@gmail.com
- Phone: +201065563874
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nigella sativa (black seed) oil versus mometasone ear drops for eczematous otitis externa
This will test whether black seed (Nigella sativa) oil works as well as mometasone ear drops for adults with eczematous otitis externa.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.